Back
Aclaris Therapeutics Vs. Equifax Industry Stock Comparison
Sell
13
ACRS
Aclaris Therapeutics
Last Price:
1.31
Seasonality Move:
4.39%
Buy
58
EFX
Equifax
Last Price:
224.64
Seasonality Move:
3.45%
Sell
13
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.26. The Score for ACRS is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
58
Equifax (EFX)
is a Buy
Is Equifax a Buy, Sell or Hold?
- The current Equifax [EFX] share price is $220.67. The Score for EFX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- EFX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
EFX Stock Price Chart
ACRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 57.25 | Buy |
Chaikin Money Flow: | 636329 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.19 - 1.25) | Buy |
Bollinger Bands (100): | (1.07 - 1.27) | Buy |
EFX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.5 | Sell |
Relative Strength Index (14 RSI): | 32.85 | Sell |
Chaikin Money Flow: | -394075 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (223.76 - 257.44) | Sell |
Bollinger Bands (100): | (235.19 - 262.33) | Sell |
ACRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.21 | Buy |
20-day SMA: | 1.21 | Buy |
50-day SMA: | 1.22 | Buy |
200-day SMA: | 3.62 | Sell |
8-day EMA: | 1.22 | Buy |
20-day EMA: | 1.22 | Buy |
50-day EMA: | 1.25 | Buy |
200-day EMA: | 3.56 | Sell |
EFX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 223.15 | Sell |
20-day SMA: | 235.64 | Sell |
50-day SMA: | 252.36 | Sell |
200-day SMA: | 221.7 | Sell |
8-day EMA: | 224.26 | Sell |
20-day EMA: | 233.33 | Sell |
50-day EMA: | 243.24 | Sell |
200-day EMA: | 230.59 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
Equifax Earnings Growth & EFX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $0.73 per share, and an increase next year of $2.17 per share.
Aclaris Therapeutics Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Equifax Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |